{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:17:14Z","timestamp":1790727434307,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12954-017-0183-9","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T08:44:39Z","timestamp":1503045879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Rationale for cannabis-based interventions in the opioid overdose crisis"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-3842","authenticated-orcid":false,"given":"Philippe","family":"Lucas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,18]]},"reference":[{"key":"183_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","volume":"65","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Seth P, David F, Scholl L. Increases in Drug and Opioid-Involved Overdose Deaths \u2014 United States, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2016;65:1445\u201352. doi: 10.15585\/mmwr.mm655051e1 .","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"183_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mi.5.1.6","volume":"5","author":"SR Hursh","year":"2005","unstructured":"Hursh SR, Galuska CM, Winger G, Woods JH. The economics of drug abuse: a quantitative assessment of drug demand. Mol Interv. 2005;5:20\u20138.","journal-title":"Mol Interv"},{"key":"183_CR3","doi-asserted-by":"crossref","unstructured":"Morris RG, TenEyck M, Barnes JC, Kovandzic T V. The effect of medical marijuana laws on crime: Evidence from state panel data, 1990\u20132006. PLoS One. 2014;9:1\u20137.","DOI":"10.1371\/journal.pone.0092816"},{"key":"183_CR4","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2105\/AJPH.2013.301612","volume":"104","author":"DM Anderson","year":"2014","unstructured":"Anderson DM, Rees DI, Sabia JJ. Medical Marijuana Laws and Suicides by Gender and Age. Am J Public Health. 2014;104:2369\u201376. doi: 10.2105\/AJPH.2013.301612 .","journal-title":"Am J Public Health"},{"key":"183_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/668812","volume":"56","author":"DM Anderson","year":"2013","unstructured":"Anderson DM, Hansen B, Rees DI. Medical marijuana laws, traffic fatalities, and alcohol consumption. J Law Econ. 2013;56:333\u201369. doi: 10.1086\/668812 .","journal-title":"J Law Econ"},{"key":"183_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2105\/AJPH.2016.303577","volume":"107","author":"J Santaella-Tenorio","year":"2017","unstructured":"Santaella-Tenorio J, Mauro CM, Wall MM, Kim JH, Cerd\u00e1 M, Keyes KM, et al. US Traffic Fatalities, 1985\u20132014, and Their Relationship to Medical Marijuana Laws. Am J Public Health. 2017;107:336\u201342. doi: 10.2105\/AJPH.2016.303577 .","journal-title":"Am J Public Health"},{"key":"183_CR7","doi-asserted-by":"publisher","unstructured":"Declues K, Perez S, Figueroa A. A 2-Year Study of \u0394 9-tetrahydrocannabinol Concentrations in Drivers: Examining Driving and Field Sobriety Test Performance. J Forensic Sci. 2016; doi: 10.1111\/1556-4029.13168 .","DOI":"10.1111\/1556-4029.13168"},{"key":"183_CR8","doi-asserted-by":"crossref","unstructured":"Bachhuber MA, Salone B, Cunningham CO, Barry CL. Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999\u20132010. JAMA Intern Med. 2014;(19104):1\u20136.","DOI":"10.1001\/jamainternmed.2014.4005"},{"key":"183_CR9","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1377\/hlthaff.2015.1661","volume":"35","author":"AC Bradford","year":"2016","unstructured":"Bradford AC, Bradford WD. Medical marijuana laws reduce prescription medication use in medicare part d. Health Aff. 2016;35:1230\u20136.","journal-title":"Health Aff"},{"key":"183_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","volume":"17","author":"KF Boehnke","year":"2016","unstructured":"Boehnke KF, Litinas E, Clauw DJ, Arnold LM, Clauw DJ, Dunegan LJ, et al. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. J Pain. 2016;17:739\u201344. doi: 10.1016\/j.jpain.2016.03.002 .","journal-title":"J Pain"},{"key":"183_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/can.2017.0012","volume":"2","author":"A Reiman","year":"2017","unstructured":"Reiman A, Welty M, Solomon P. Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report. Cannabis Cannabinoid Res. 2017;2:160\u20136. doi: 10.1089\/can.2017.0012 .","journal-title":"Cannabis Cannabinoid Res"},{"key":"183_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugpo.2017.01.011","volume":"42","author":"P Lucas","year":"2017","unstructured":"Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. Int J Drug Policy. 2017;42:30\u20135. doi: 10.1016\/j.drugpo.2017.01.011 .","journal-title":"Int J Drug Policy"},{"key":"183_CR13","unstructured":"Hager M. Among veterans, opioid prescription requests down in step with rise in medical pot. Globe Mail. 2016. http:\/\/www.theglobeandmail.com\/news\/national\/among-veterans-opioid-prescription-requests-down-in-step-with-rise-in-medical-pot\/article30285591\/ . Accessed 14 Aug. 2017."},{"key":"183_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/clpt.2011.188","volume":"90","author":"DI Abrams","year":"2011","unstructured":"Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther. 2011;90:844\u201351. doi: 10.1038\/clpt.2011.188 .","journal-title":"Clin Pharmacol Ther"},{"key":"183_CR15","doi-asserted-by":"crossref","unstructured":"Pugh G, Smith PB, Dombrowski DS, Welch SP. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord. J Pharmacol Exp Ther. 1996;279. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8930163 . Accessed 10 May 2017.","DOI":"10.1016\/S0022-3565(25)21168-5"},{"key":"183_CR16","doi-asserted-by":"crossref","unstructured":"Welch SP, Stevens DL. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J Pharmacol Exp Ther. 1992;262:10\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1320680 . Accessed 10 May 2017.","DOI":"10.1016\/S0022-3565(25)10720-9"},{"key":"183_CR17","doi-asserted-by":"crossref","unstructured":"Welch SP, Eads M. Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res. 1999;848:183\u201390. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10612710 . Accessed 10 May 2017.","DOI":"10.1016\/S0006-8993(99)01908-3"},{"key":"183_CR18","doi-asserted-by":"crossref","unstructured":"Welch SP, Thomas C, Patrick GS. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine. J Pharmacol Exp Ther. 1995;272:310\u201321. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7815346 . Accessed 10 May 2017.","DOI":"10.1016\/S0022-3565(25)24328-2"},{"key":"183_CR19","doi-asserted-by":"crossref","unstructured":"Pugh G, Welch SP, Bass PP. Modulation of free intracellular calcium and cAMP by morphine and cannabinoids, alone and in combination in mouse brain and spinal cord synaptosomes. Pharmacol Biochem Behav. 1994;49:1093\u2013100. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7886081 . Accessed 10 May 2017.","DOI":"10.1016\/0091-3057(94)90270-4"},{"key":"183_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","volume":"36","author":"A Kolodny","year":"2015","unstructured":"Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, et al. The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction. Annu Rev Public Health. 2015;36:559\u201374. doi: 10.1146\/annurev-publhealth-031914-122957 .","journal-title":"Annu Rev Public Health"},{"key":"183_CR21","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","volume":"376","author":"DJ Nutt","year":"2010","unstructured":"Nutt DJ, King LA, Phillips LD. Drug harms in the UK: A multicriteria decision analysis. Lancet. 2010;376:1558\u201365.","journal-title":"Lancet"},{"key":"183_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/TCRM.S1928","volume":"4","author":"EB Russo","year":"2008","unstructured":"Russo EB. Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag. 2008;4:245\u201359.","journal-title":"Ther Clin Risk Manag"},{"key":"183_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11916-015-0524-x","volume":"19","author":"B Jensen","year":"2015","unstructured":"Jensen B, Chen J, Furnish T, Wallace M. Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence. Curr Pain Headache Rep. 2015;19:50. doi: 10.1007\/s11916-015-0524-x .","journal-title":"Curr Pain Headache Rep"},{"key":"183_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","volume":"68","author":"DI Abrams","year":"2007","unstructured":"Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, et al. Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial. Neurology. 2007;68:515\u201321. doi: 10.1212\/01.wnl.0000253187.66183.9c .","journal-title":"Neurology"},{"key":"183_CR25","doi-asserted-by":"publisher","unstructured":"Ware MA, Wang T, Shapiro S, Collet J-P. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). J Pain. 2015; doi: 10.1016\/j.jpain.2015.07.014 .","DOI":"10.1016\/j.jpain.2015.07.014"},{"key":"183_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1503\/cmaj.090495","volume":"182","author":"MA Ware","year":"2010","unstructured":"Ware MA, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, et al. Smoked cannabis for chronic neuropathic pain: A randomized controlled trial. CMAJ. 2010;182:1\u20138.","journal-title":"CMAJ"},{"key":"183_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.drugpo.2013.08.010","volume":"24","author":"Z Walsh","year":"2013","unstructured":"Walsh Z, Callaway R, Belle-Isle L, Capler R, Kay R, Lucas P, et al. Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. Int J Drug Policy. 2013;24:511\u20136. doi: 10.1016\/j.drugpo.2013.08.010 .","journal-title":"Int J Drug Policy"},{"key":"183_CR28","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.lfs.2003.09.038","volume":"74","author":"DL Cichewicz","year":"2004","unstructured":"Cichewicz DL. Synergistic interactions between cannabinoid and opioid analgesics. Life Sci. 2004;74:1317\u201324. doi: 10.1016\/j.lfs.2003.09.038 .","journal-title":"Life Sci"},{"key":"183_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","volume":"17","author":"KF Boehnke","year":"2016","unstructured":"Boehnke KF, Litinas E, Clauw DJ. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. J Pain. 2016;17:739\u201344. doi: 10.1016\/j.jpain.2016.03.002 .","journal-title":"J Pain"},{"key":"183_CR30","doi-asserted-by":"publisher","unstructured":"Lucas P, Walsh Z, Crosby K, Callaway R, Belle-Isle L, Kay R, et al. Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug Alcohol Rev. 2016;35(3):326\u201333. doi: 10.1111\/dar.12323 .","DOI":"10.1111\/dar.12323"},{"key":"183_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/16066359.2012.733465","volume":"21","author":"P Lucas","year":"2013","unstructured":"Lucas P, Reiman A, Earleywine M, McGowan SK, Oleson M, Coward MP, et al. Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addict Res Theory. 2013;21:435\u201342. doi: 10.3109\/16066359.2012.733465 .","journal-title":"Addict Res Theory"},{"key":"183_CR32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2147\/JPR.S134330","volume":"10","author":"J Corroon","year":"2017","unstructured":"Corroon J, Mischley L, Sexton M. Cannabis as a substitute for prescription drugs \u2013 a cross-sectional study. J Pain Res. 2017;10:989\u201398. doi: 10.2147\/JPR.S134330 .","journal-title":"J Pain Res"},{"key":"183_CR33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2524.2007.00722.x","volume":"16","author":"AE Reiman","year":"2008","unstructured":"Reiman AE. Self-efficacy, social support and service integration at medical cannabis facilities in the San Francisco Bay area of California. Health Soc Care Community. 2008;16:31\u201341.","journal-title":"Health Soc Care Community"},{"key":"183_CR34","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1055-9965.EPI-06-0330","volume":"15","author":"M Hashibe","year":"2006","unstructured":"Hashibe M, Morgenstern H, Cui Y, Tashkin DP, Zhang ZF, Cozen W, et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: Results of a population-based case\u2013control study. Cancer Epidemiol Biomark Prev. 2006;15:1829\u201334.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"183_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/02791072.2013.805976","volume":"45","author":"A Hazekamp","year":"2013","unstructured":"Hazekamp A, Ware MA, Muller-Vahl K, Abrams D, Grotenhermen F. The medicinal use of cannabis and cannabinoids\u2014An international cross-sectional survey on administration forms. J Psychoactive Drugs. 2013;45:199\u2013210.","journal-title":"J Psychoactive Drugs"},{"key":"183_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/can.2016.0010","volume":"1","author":"C Cuttler","year":"2016","unstructured":"Cuttler C, Mischley LK, Sexton M. Sex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users. Cannabis Cannabinoid Res. 2016;1:166\u201375. doi: 10.1089\/can.2016.0010 .","journal-title":"Cannabis Cannabinoid Res"},{"key":"183_CR37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpr.2016.10.002","volume":"51","author":"Z Walsh","year":"2017","unstructured":"Walsh Z, Gonzalez R, Crosby K, Thiessen M S, Carroll C, Bonn-Miller MO. Medical cannabis and mental health: A guided systematic review. Clin Psychol Rev. 2017;51:15\u201329.","journal-title":"Clin Psychol Rev"},{"key":"183_CR38","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1037\/a0037302","volume":"28","author":"PH Smith","year":"2014","unstructured":"Smith PH, Homish GG, Collins RL, Giovino GA, White HR, Leonard KE. Couples\u2019 marijuana use is inversely related to their intimate partner violence over the first 9 years of marriage. Psychol Addict Behav. 2014;28:734\u201342. doi: 10.1037\/a0037302 .","journal-title":"Psychol Addict Behav"},{"key":"183_CR39","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","volume":"29","author":"Y Ren","year":"2009","unstructured":"Ren Y, Whittard J, Higuera-Matas A, Morris CV, Hurd YL. Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. J Neurosci. 2009;29:14764\u20139. doi: 10.1523\/JNEUROSCI.4291-09.2009 .","journal-title":"J Neurosci"},{"key":"183_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/can.2016.0034","volume":"2","author":"K Iffland","year":"2017","unstructured":"Iffland K, Grotenhermen F. An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis Cannabinoid Res. 2017;2:139\u201354. doi: 10.1089\/can.2016.0034 .","journal-title":"Cannabis Cannabinoid Res"},{"key":"183_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/10550490902927785","volume":"18","author":"WN Raby","year":"2009","unstructured":"Raby WN, Carpenter KM, Rothenberg J, Brooks AC, Jiang H, Sullivan M, et al. Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. Am J Addict. 2009;18:301\u20138. doi: 10.1080\/10550490902927785 .","journal-title":"Am J Addict"},{"key":"183_CR42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1521-0391.2013.12044.x","volume":"22","author":"JL Scavone","year":"2013","unstructured":"Scavone JL, Sterling RC, Weinstein SP, Van Bockstaele EJ. Impact of cannabis use during stabilization on methadone maintenance treatment. Am J Addict. 2013;22:344\u201351.","journal-title":"Am J Addict"},{"key":"183_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.drugalcdep.2009.07.003","volume":"105","author":"AK Elkader","year":"2009","unstructured":"Elkader AK, Brands B, Callaghan R, Sproule BA. Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment. Drug Alcohol Depend. 2009;105:209\u201314. doi: 10.1016\/j.drugalcdep.2009.07.003 .","journal-title":"Drug Alcohol Depend"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:26:41Z","timestamp":1750793201000},"score":1,"resource":{"primary":{"URL":"http:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-017-0183-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,18]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1186\/s12954-017-0183-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,18]]},"article-number":"58"}}